Guidance
Creator
Unknown authorBibliographic Citation
Washington, DC: Food and Drug Administration [FDA], 2010 January 13: ? p. [Online]. Accessed: http://www.regulations.gov [2010 February 15]
Permanent Link
Find in a Libraryhttp://hdl.handle.net/10822/1024723
Date
2010-01-13Subject
Publisher
United States. Food and Drug Administration [FDA]
Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Guidance for Industry: Supplemental Guidance on Testing for Replication-Competent Retrovirus in Retroviral Vector-Based Gene Therapy Products and During Follow-Up of Patients in Clinical Trials Using Retroviral Vectors
Center for Biologics Evaluation and Research [CBER] (United States) (2001-02-10)